Trial · NCT05481216
Results by group88
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 88
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Composite Primary End Point (Critical Care Admission, Palliative Discharge When Discharged From Hospital, or Mortality Within the 6 Weeks After Diagnosis of COVID-19) Events | PLWHIV With COVID-19 Cases | 66 | Events | ||
| Number of Composite Primary End Point (Critical Care Admission, Palliative Discharge When Discharged From Hospital, or Mortality Within the 6 Weeks After Diagnosis of COVID-19) Events | HIV Seronegative Patients With COVID-19 Controls | 67 | Events | ||
| Kaplan-Meier Estimate of Primary End Point | PLWHIV With COVID-19 Cases | 13.6 | 95% Confidence Interval 10.8 to 17.0 | percentage of events | |
| Kaplan-Meier Estimate of Primary End Point | HIV Seronegative Patients With COVID-19 Controls | 6.1 | 95% Confidence Interval 4.8 to 7.6 | percentage of events | |
| Number of Palliative Discharge | PLWHIV With COVID-19 Cases | 1 | Participants | ||
| Number of Palliative Discharge | HIV Seronegative Patients With COVID-19 Controls | 0 | Participants | ||
| Mortality | PLWHIV With COVID-19 Cases | 24 | Participants | ||
| Mortality | HIV Seronegative Patients With COVID-19 Controls | 23 | Participants | ||
| Number of Critical Care Admission Events | PLWHIV With COVID-19 Cases | 55 | events | ||
| Number of Critical Care Admission Events | HIV Seronegative Patients With COVID-19 Controls | 58 | events | ||
| HIV Viral Load | PLWHIV With COVID-19 Cases | <50 | 427 | copies/ml | |
| HIV Viral Load | PLWHIV Without COVID-19 Controls | <50 | 888 | copies/ml | |
| HIV Viral Load | PLWHIV With COVID-19 Cases | ≥50 | 73 | copies/ml | |
| HIV Viral Load | PLWHIV Without COVID-19 Controls | ≥50 | 104 | copies/ml | |
| Number of Hospitalisation Events | PLWHIV With COVID-19 Cases | 200 | events | ||
| Number of Hospitalisation Events | HIV Seronegative Patients With COVID-19 Controls | 208 | events | ||
| Length of Hospital Stay | PLWHIV With COVID-19 Cases | 11 | 95% Confidence Interval 9 to 12 | days | |
| Length of Hospital Stay | HIV Seronegative Patients With COVID-19 Controls | 9 | 95% Confidence Interval 8 to 11 | days | |
| Length of Stay in ICU | PLWHIV With COVID-19 Cases | 18 | 95% Confidence Interval 11 to 33 | days | |
| Length of Stay in ICU | HIV Seronegative Patients With COVID-19 Controls | 7 | 95% Confidence Interval 4 to 21 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05481216/results